Dan Cui

1.4k total citations
67 papers, 1.0k citations indexed

About

Dan Cui is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Dan Cui has authored 67 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Surgery and 14 papers in Epidemiology. Recurrent topics in Dan Cui's work include Amyloidosis: Diagnosis, Treatment, Outcomes (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Dan Cui is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Dan Cui collaborates with scholars based in China, Japan and United States. Dan Cui's co-authors include Yoshinobu Hoshii, Tokuhiro Ishihara, Hiroo Kawano, Yingfu Liu, Gaoliang Ouyang, Zhengjie Huang, Bo Zhai, Toshikazu Gondo, Mutsuo Takahashi and Mihoko Setoguchi and has published in prestigious journals such as Scientific Reports, FEBS Letters and Cellular and Molecular Life Sciences.

In The Last Decade

Dan Cui

65 papers receiving 981 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Cui China 18 442 195 151 136 123 67 1.0k
Gabriella B. Gajdos United States 15 440 1.0× 256 1.3× 110 0.7× 182 1.3× 216 1.8× 20 975
David Kuninger United States 17 514 1.2× 87 0.4× 87 0.6× 69 0.5× 27 0.2× 22 835
Jane Hoover‐Plow United States 17 422 1.0× 443 2.3× 99 0.7× 145 1.1× 25 0.2× 52 1.6k
Rui Gong China 18 545 1.2× 164 0.8× 172 1.1× 138 1.0× 43 0.3× 54 1.2k
T Hayakawa Japan 21 441 1.0× 657 3.4× 317 2.1× 188 1.4× 131 1.1× 107 1.6k
Olga Genina Israel 22 429 1.0× 269 1.4× 122 0.8× 204 1.5× 223 1.8× 30 1.4k
Yukisato Kitamura Japan 21 311 0.7× 295 1.5× 415 2.7× 200 1.5× 142 1.2× 47 1.1k
Anthony L. Guerrerio United States 16 672 1.5× 276 1.4× 68 0.5× 187 1.4× 29 0.2× 35 1.7k
Jun Qian China 18 357 0.8× 84 0.4× 91 0.6× 108 0.8× 48 0.4× 71 864
Kazuhiko Yamamura Japan 23 595 1.3× 117 0.6× 196 1.3× 249 1.8× 113 0.9× 52 1.7k

Countries citing papers authored by Dan Cui

Since Specialization
Citations

This map shows the geographic impact of Dan Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Cui more than expected).

Fields of papers citing papers by Dan Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Cui. The network helps show where Dan Cui may publish in the future.

Co-authorship network of co-authors of Dan Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Cui. A scholar is included among the top collaborators of Dan Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Cui. Dan Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sands, Bruce E., S Schreiber, Silvio Danese, et al.. (2025). A Phase 2 Study of MORF-057, an Oral α4β7 Integrin Inhibitor in Moderately to Severely Active Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 24(2). 525–534.
3.
Cui, Dan, et al.. (2024). Identification and validation of a prognostic model based on four genes related to satellite nodules in hepatocellular carcinoma. Scientific Reports. 14(1). 15633–15633. 1 indexed citations
4.
Chi, Jiachang, Min Ding, Zhi Wang, et al.. (2021). Pathologic Diagnosis and Genetic Analysis of Sequential Biopsy Following Coaxial Low-Power Microwave Thermal Coagulation For Pulmonary Ground-Glass Opacity Nodules. CardioVascular and Interventional Radiology. 44(8). 1204–1213. 8 indexed citations
5.
Ding, Min, Xiaodong Zhao, Mingchen Zhao, et al.. (2020). Prognostic Nomogram for Patients with Hepatocellular Carcinoma After Thermal Ablation. CardioVascular and Interventional Radiology. 43(11). 1621–1630. 4 indexed citations
6.
Cui, Dan, Yuzhu Zuo, Shanshan Huo, et al.. (2018). Recombinant chicken interleukin-7 as a potent adjuvant increases the immunogenicity and protection of inactivated infectious bursal disease vaccine. Veterinary Research. 49(1). 10–10. 13 indexed citations
8.
Wu, Tiantian, Jingwen Huang, Zhengjie Huang, et al.. (2017). Deficiency of periostin impairs liver regeneration in mice after partial hepatectomy. Matrix Biology. 66. 81–92. 11 indexed citations
9.
Zhong, Fei, Yonghong Zhang, Shanshan Huo, et al.. (2016). Construction of Bacillus subtilis strain engineered for expression of porcine β-defensin-2/cecropin P1 fusion antimicrobial peptides and its growth-promoting effect and antimicrobial activity. Asian-Australasian Journal of Animal Sciences. 30(4). 576–584. 29 indexed citations
10.
Ma, Sicong, Min Ding, Jiang Li, et al.. (2016). Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma: clinical outcomes and prognostic factors. Journal of Cancer Research and Clinical Oncology. 143(1). 131–142. 28 indexed citations
11.
Wang, Yufeng, Yasuhiro Kuramitsu, Byron Baron, et al.. (2015). PERK/CHOP contributes to the CGK733-induced vesicular calcium sequestration which is accompanied by non-apoptotic cell death. Oncotarget. 6(28). 25252–25265. 13 indexed citations
12.
13.
Kawano, Hiroo, Shinsuke Tanaka, Aya Ishii, et al.. (2011). Osteoclast-rich undifferentiated carcinoma of the urinary bladder: An immunohistochemical study. Pathology - Research and Practice. 207(11). 722–727. 6 indexed citations
16.
Cui, Dan, Yoshinobu Hoshii, Hiroo Kawano, et al.. (2007). Experimental AA amyloidosis in mice is inhibited by treatment with triptolide, a purified traditional Chinese medicine. International Immunopharmacology. 7(9). 1232–1240. 5 indexed citations
17.
Hoshii, Yoshinobu, et al.. (2006). Immunohistochemical study of immunoglobulin light chain amyloidosis with antibodies to the immunoglobulin light chain variable region. Pathology International. 56(6). 324–330. 18 indexed citations
18.
Hoshii, Yoshinobu, Mihoko Setoguchi, Takako Iwata, et al.. (2001). Useful polyclonal antibodies against synthetic peptides corresponding to immunoglobulin light chain constant region for immunohistochemical detection of immunoglobulin light chain amyloidosis. Pathology International. 51(4). 264–270. 60 indexed citations
19.
Vickers, S., Anthony D. Theoharides, Byron H. Arison, et al.. (1999). In Vitro and In Vivo Studies on the Metabolism of Tirofiban. Drug Metabolism and Disposition. 27(11). 1360–1366. 32 indexed citations
20.
OSA, Takuro, et al.. (1994). Pretreatment with Porcine Relaxin and Mg Ions Enhances Inhibitory Effects of Dibutyryl Cyclic AMP in Longitudinal Muscle of Estrogen-Treated Rat Myometrium.. The Journal of Physiological Sciences. 44(3). 319–323. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026